March 27, 2018 / 10:52 PM / 4 months ago

BRIEF-Cynata Therapeutics Says U.S. FDA Granted Cynata Orphan Drug Designation For CYP-001

March 28 (Reuters) - Cynata Therapeutics Ltd:

* UNITED STATES FDA GRANTED CYNATA ORPHAN DRUG DESIGNATION FOR CYP-001 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below